Drug intelligence / Profile preview

ambrosia trifida pollen + ambrosia artemisiifolia pollen

Development stage
Unknown
Lead developer
Greer Laboratories
Administration
Subcutaneous, Intradermal, Percutaneous
01

Overview

A **combination allergenic extract** composed of pollen from *Ambrosia trifida* and *Ambrosia artemisiifolia* used in allergen immunotherapy and diagnostic allergy testing for ragweed sensitization. This product is marketed as a non-standardized biologic allergen extract for **skin test diagnosis** in patients with a clinical history of ragweed allergy and, after dilution, for **subcutaneous immunotherapy**. Its therapeutic effect is based on controlled exposure to ragweed allergens to modulate the allergic immune response, while its diagnostic use relies on provoking an IgE-mediated hypersensitivity response in sensitized individuals. The product has been marketed by Greer Laboratories and is distinct from the approved sublingual short ragweed tablet product that contains only *Ambrosia artemisiifolia*.

Other names
short and giant ragweed pollen mixshort and giant ragweed pollen mix allergenic extractambrosia artemisiifolia and ambrosia trifida solution
02

Targets

A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)

Beyond the preview

Go deeper on ambrosia trifida pollen + ambrosia artemisiifolia pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ambrosia trifida pollen + ambrosia artemisiifolia pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call